Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Lund University
Biotech
Cambridge, Lund University spinout Wren pens Eisai pact
U.K.-based alpha-synuclein biotech Wren will partner with Japanese pharma Eisai to seek out new ways of targeting neuro disorders.
Ben Adams
Nov 30, 2020 8:53am
Alzheimer's blood tests show promise, giving decades of warning
Jul 28, 2020 2:08pm
Tamping down stroke damage with a drug that shields neurons
Jul 2, 2020 8:30am
Cell therapy restores mobility in rodent models of stroke
Apr 10, 2020 8:45am
Novo Nordisk owner puts up $43M to analyze proteins
Jan 25, 2018 10:40am
Targeting immune cells could treat diabetes and high blood pressure
Mar 17, 2017 9:08am